Cargando…

Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals

BACKGROUND: The Consolidated Standards of Reporting Trials (CONSORT) statement is a device to standardize reporting and improve the quality of controlled trials. However, little attention is paid to the statistical components in the CONSORT checklist. The present study evaluates the randomized contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Satpute, Sachin, Mehta, Manthan, Bhete, Sandeep, Kurle, Dnyneshwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936071/
https://www.ncbi.nlm.nih.gov/pubmed/27453829
http://dx.doi.org/10.4103/2229-3485.184816
_version_ 1782441508681547776
author Satpute, Sachin
Mehta, Manthan
Bhete, Sandeep
Kurle, Dnyneshwar
author_facet Satpute, Sachin
Mehta, Manthan
Bhete, Sandeep
Kurle, Dnyneshwar
author_sort Satpute, Sachin
collection PubMed
description BACKGROUND: The Consolidated Standards of Reporting Trials (CONSORT) statement is a device to standardize reporting and improve the quality of controlled trials. However, little attention is paid to the statistical components in the CONSORT checklist. The present study evaluates the randomized controlled trials [RCTs] published in five high impact pharmacology journals with respect to its statistical methods. METHODS: Randomized Controlled Trials [RCTs] published in the years 2013 & 2014 in five pharmacology journals with high impact factor, The Journal of Clinical Pharmacology (JCP), British Journal of Clinical Pharmacology (BJCP), European Journal of Clinical Pharmacology (EJCP), Journal of Pharmacology & Pharmacotherapeutics (JPP) and Indian Journal of Pharmacology (IJP) were assessed for adherence to the statistical components of CONSORT statement. RESULTS: Of the 174 RCTs analysed, 103 described the method of sample size calculation. Of the five journals, maximum reports in JCP (34/50) and minimum in IJP (13/31) adhered to the CONSORT checklist [item 7a-sample size calculation]. Most reports mentioned the statistical methods used for analysis of data. (171/174) as per the checklist [item 12=statistical methods used]. Analysis of variance (ANOVA) was the most commonly used test (88/174). The software used for statistical analysis was mentioned in 111 RCTs and SPSS was used more frequently (58/111). The exact p value was stated in 108 reports. Certain errors in statistical analysis were also noted (40/174). CONCLUSION: These findings show inconsistencies and non- adherence to the statistical components of the CONSORT statement especially with respect to sample size calculation. Special attention must be paid to the statistical accuracy of the reports.
format Online
Article
Text
id pubmed-4936071
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-49360712016-07-22 Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals Satpute, Sachin Mehta, Manthan Bhete, Sandeep Kurle, Dnyneshwar Perspect Clin Res Original Article BACKGROUND: The Consolidated Standards of Reporting Trials (CONSORT) statement is a device to standardize reporting and improve the quality of controlled trials. However, little attention is paid to the statistical components in the CONSORT checklist. The present study evaluates the randomized controlled trials [RCTs] published in five high impact pharmacology journals with respect to its statistical methods. METHODS: Randomized Controlled Trials [RCTs] published in the years 2013 & 2014 in five pharmacology journals with high impact factor, The Journal of Clinical Pharmacology (JCP), British Journal of Clinical Pharmacology (BJCP), European Journal of Clinical Pharmacology (EJCP), Journal of Pharmacology & Pharmacotherapeutics (JPP) and Indian Journal of Pharmacology (IJP) were assessed for adherence to the statistical components of CONSORT statement. RESULTS: Of the 174 RCTs analysed, 103 described the method of sample size calculation. Of the five journals, maximum reports in JCP (34/50) and minimum in IJP (13/31) adhered to the CONSORT checklist [item 7a-sample size calculation]. Most reports mentioned the statistical methods used for analysis of data. (171/174) as per the checklist [item 12=statistical methods used]. Analysis of variance (ANOVA) was the most commonly used test (88/174). The software used for statistical analysis was mentioned in 111 RCTs and SPSS was used more frequently (58/111). The exact p value was stated in 108 reports. Certain errors in statistical analysis were also noted (40/174). CONCLUSION: These findings show inconsistencies and non- adherence to the statistical components of the CONSORT statement especially with respect to sample size calculation. Special attention must be paid to the statistical accuracy of the reports. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4936071/ /pubmed/27453829 http://dx.doi.org/10.4103/2229-3485.184816 Text en Copyright: © Perspectives in Clinical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Satpute, Sachin
Mehta, Manthan
Bhete, Sandeep
Kurle, Dnyneshwar
Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title_full Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title_fullStr Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title_full_unstemmed Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title_short Assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
title_sort assessment of adherence to the statistical components of consolidated standards of reporting trials statement for quality of reports on randomized controlled trials from five pharmacology journals
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936071/
https://www.ncbi.nlm.nih.gov/pubmed/27453829
http://dx.doi.org/10.4103/2229-3485.184816
work_keys_str_mv AT satputesachin assessmentofadherencetothestatisticalcomponentsofconsolidatedstandardsofreportingtrialsstatementforqualityofreportsonrandomizedcontrolledtrialsfromfivepharmacologyjournals
AT mehtamanthan assessmentofadherencetothestatisticalcomponentsofconsolidatedstandardsofreportingtrialsstatementforqualityofreportsonrandomizedcontrolledtrialsfromfivepharmacologyjournals
AT bhetesandeep assessmentofadherencetothestatisticalcomponentsofconsolidatedstandardsofreportingtrialsstatementforqualityofreportsonrandomizedcontrolledtrialsfromfivepharmacologyjournals
AT kurlednyneshwar assessmentofadherencetothestatisticalcomponentsofconsolidatedstandardsofreportingtrialsstatementforqualityofreportsonrandomizedcontrolledtrialsfromfivepharmacologyjournals